Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nefopam and oxycodone pain model biomarker study in healthy volunteers
NL-OMON58003Completed
- Sponsor
- Centre for Human Drug Research
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nefopam and oxycodone in pain, sponsored by Centre for Human Drug Research. Primary endpoints: Temporal summation magnitude on normal skin, Allodynia presence by cotton swab and 15 more. Started Sep 2025; status: completed.
02
Drugs
nefopamoxycodone
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON58003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58003.